JP2005536463A5 - - Google Patents

Download PDF

Info

Publication number
JP2005536463A5
JP2005536463A5 JP2004501431A JP2004501431A JP2005536463A5 JP 2005536463 A5 JP2005536463 A5 JP 2005536463A5 JP 2004501431 A JP2004501431 A JP 2004501431A JP 2004501431 A JP2004501431 A JP 2004501431A JP 2005536463 A5 JP2005536463 A5 JP 2005536463A5
Authority
JP
Japan
Prior art keywords
oxoestradi
dien
benzaldehyde
oxime
pentafluoroethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004501431A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005536463A (ja
Filing date
Publication date
Priority claimed from DE10221034A external-priority patent/DE10221034A1/de
Application filed filed Critical
Priority claimed from PCT/EP2003/004686 external-priority patent/WO2003093292A1/de
Publication of JP2005536463A publication Critical patent/JP2005536463A/ja
Publication of JP2005536463A5 publication Critical patent/JP2005536463A5/ja
Pending legal-status Critical Current

Links

JP2004501431A 2002-05-03 2003-05-05 17α−フルオロアルキル−11β−ベンズアルドキシムステロイド、それらの製造方法、これらのステロイド類を含有する製剤及び医薬品製造のためのそれらの使用 Pending JP2005536463A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10221034A DE10221034A1 (de) 2002-05-03 2002-05-03 17alpha-Fluoralkyl-11ß-benzaldoxim-Steroide, Verfahren zu deren Herstellung, diese Steroide enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
US44940103P 2003-02-25 2003-02-25
PCT/EP2003/004686 WO2003093292A1 (de) 2002-05-03 2003-05-05 17α-FLUORALKYL-11β-BENZALDOXIM-STEROIDE, VERFAHREN ZU DEREN HERSTELLUNG, DIESE STEROIDE ENTHALTENDE PHARMAZEUTISCHE PRÄPARATE SOWIE DEREN VERWENDUNG ZUR HERSTELLUNG VON ARZNEIMITTELN

Publications (2)

Publication Number Publication Date
JP2005536463A JP2005536463A (ja) 2005-12-02
JP2005536463A5 true JP2005536463A5 (cg-RX-API-DMAC7.html) 2006-06-22

Family

ID=29403591

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004501431A Pending JP2005536463A (ja) 2002-05-03 2003-05-05 17α−フルオロアルキル−11β−ベンズアルドキシムステロイド、それらの製造方法、これらのステロイド類を含有する製剤及び医薬品製造のためのそれらの使用

Country Status (8)

Country Link
EP (1) EP1501859B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005536463A (cg-RX-API-DMAC7.html)
AT (1) ATE307823T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003227717A1 (cg-RX-API-DMAC7.html)
DE (1) DE50301507D1 (cg-RX-API-DMAC7.html)
DK (1) DK1501859T3 (cg-RX-API-DMAC7.html)
ES (1) ES2252670T3 (cg-RX-API-DMAC7.html)
WO (1) WO2003093292A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006054535A1 (de) 2006-11-15 2008-05-21 Bayer Schering Pharma Aktiengesellschaft Progesteronrezeptorantagonisten
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
US20130029953A1 (en) * 2011-07-28 2013-01-31 Klaus Nickisch Progesterone antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19706061A1 (de) * 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
DE19745085A1 (de) * 1997-10-11 1999-04-15 Jenapharm Gmbh 11ß-Benzaldoxim-9alpha,10alpha-epoxy-estr-4-en-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate

Similar Documents

Publication Publication Date Title
CN101466725B (zh) 作为心血管病症药剂的雄甾烷和雄甾烯的氨基衍生物
JPH06192287A (ja) 心臓血管系に有効な17−アリールおよび17−ヘテロシクリル−14β−5α−アンドロスタン、アンドロステン、およびアンドロスタジエン誘導体、これらの調製方法、およびこれらを含む医薬用組成物
US11117925B2 (en) Methods for the preparation of deoxycholic acid, and intermediates useful in the preparation of deoxycholic acid
US20070142342A1 (en) Pharmaceutical compounds
JP2004507519A5 (cg-RX-API-DMAC7.html)
EP0280618B1 (fr) Nouveaux 19-nor stéroîdes substitués en position 7, leur préparation, leur application comme médicaments, les compositions pharmaceutiques les renfermant
JP2009533392A5 (cg-RX-API-DMAC7.html)
JP2023539828A5 (cg-RX-API-DMAC7.html)
JPH0649674B2 (ja) 第二アミドのα−メチレン炭素原子をヨウ素化または臭素化する方法
JP2008530106A5 (cg-RX-API-DMAC7.html)
JP2005502603A5 (cg-RX-API-DMAC7.html)
CN107987116B (zh) 一类鹅去氧胆酸衍生物、其制备方法和医药用途
ES2252670T3 (es) Esteroides con fluoroalquilo en 17a y benzaldoxima en 11beta, procedimiento para su preparacion, formulaciones farmaceuticas que contienen estos esteroides, asi como su utilizacion para la produccion de medicamentos.
US20100087653A1 (en) Novel process for the preparation of lercanidipine
JP2000502661A (ja) 2―クロロ―5―クロロメチルチアゾールの合成方法
EP0583579A2 (en) New 17-hydroxyiminomethyl-5beta, 14beta-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
JP2008512421A5 (cg-RX-API-DMAC7.html)
CN1038648A (zh) 新的△4-雄(甾)烯衍生物
US5521167A (en) Cyclopentanperhydrophenanthren-17β-(hydroxy or alkoxy)-17α-(Aryl or heterocyclyl)-3β-derivatives active on the cardiovascular system, and pharmaceutical compositions containing same
US8044223B2 (en) Crystalline 19-norsteroids
CA2163935C (en) 17-(3-imino-2-alkypropenyl)-5.beta., 14.beta.-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
AU2005256109A8 (en) Process for the preparation of anastrozole
JP2024504378A5 (cg-RX-API-DMAC7.html)
JP4311889B2 (ja) (メタ)アクリル酸無水物の製造方法
JP3220733B2 (ja) アセトアミジン類、その製法、およびそれを用いるアセトアミド類の製造方法